GenMark Diagnostics (GNMK) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS
GenMark Diagnostics (NASDAQ:GNMK) posted its quarterly earnings results on Monday. The company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.02, American Banking News.com reports. The company had revenue of $6.55 million for the quarter, compared to the consensus estimate of $4.79 million.
GenMark Diagnostics (NASDAQ:GNMK) traded up 0.27% on Monday, hitting $11.21. 177,236 shares of the company’s stock traded hands. GenMark Diagnostics has a 52-week low of $8.48 and a 52-week high of $14.18. The stock’s 50-day moving average is $11.82 and its 200-day moving average is $11.23. The company’s market cap is $466.4 million.
GenMark Diagnostics, Inc (NASDAQ:GNMK) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.